KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Inventory (2016 - 2022)

Historic Inventory for TherapeuticsMD (TXMD) over the last 13 years, with Q3 2022 value amounting to $6.7 million.

  • TherapeuticsMD's Inventory fell 897.85% to $6.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $6.7 million, marking a year-over-year decrease of 897.85%. This contributed to the annual value of $7.6 million for FY2021, which is 464.16% down from last year.
  • Latest data reveals that TherapeuticsMD reported Inventory of $6.7 million as of Q3 2022, which was down 897.85% from $6.1 million recorded in Q2 2022.
  • TherapeuticsMD's 5-year Inventory high stood at $14.6 million for Q1 2020, and its period low was $1.6 million during Q1 2018.
  • Moreover, its 5-year median value for Inventory was $7.4 million (2019), whereas its average is $7.1 million.
  • In the last 5 years, TherapeuticsMD's Inventory soared by 34288.75% in 2019 and then tumbled by 4971.06% in 2021.
  • TherapeuticsMD's Inventory (Quarter) stood at $3.3 million in 2018, then skyrocketed by 262.97% to $11.9 million in 2019, then crashed by 32.61% to $8.0 million in 2020, then dropped by 4.64% to $7.6 million in 2021, then fell by 12.08% to $6.7 million in 2022.
  • Its last three reported values are $6.7 million in Q3 2022, $6.1 million for Q2 2022, and $9.0 million during Q1 2022.